March 29, 2023 Leading by Example in Gender Diversity Among Executive Leadership Alnylam ranked #1 among MA public companies in board of directors gender diversity and #3 in executive leadership gender diversity in the 2023 WPG report.   Read More ›
March 2, 2023 Alnylam Named One of Fast Company's Most Innovative Companies for 2023 Alnylam is one of Fast Company's Most Innovative Companies for 2023, and is ranked #5 in the Medicines and Therapeutics category. Read More ›
July 13, 2022 Partnering with Nucleate to Support Young Biotech Entrepreneurs Alnylam is partnering with Nucleate to remove barriers for young biotech entrepreneurs... Read More ›
October 28, 2021 Alnylam Names Dr. Yvonne Greenstreet New CEO Dr. Yvonne Greenstreet, currently Alnylam's President and COO, has been named Alnylam's new CEO effective year-end 2021, taking over from Dr. John Maraganore. Read More ›
April 26, 2021 Diversity Equity & Inclusion at Alnylam: Building on the Momentum to Create Lasting Impact ... Sara Nochur, Alnylam's Chief Diversity, Equity & Inclusion Officer talks about DE&I at Alnylam and her role leading the company's efforts. Read More ›
December 7, 2020 Alnylam Publishes Its 1st-Ever Rare Disease Trend Report Alnylam's 2020 Rare Disease Trend Report features findings from interviews with 30 U.S. payer and plan decision-makers about barriers to orphan drug access. Read More ›
August 6, 2020 Alnylam Promotes Dr. Yvonne Greenstreet to President & COO Dr. Yvonne Greenstreet, has been elevated to the role of President of Alnylam. She will retain her COO role as well. Read More ›
June 15, 2020 Rethinking R&D to Prime it for Future Success Much of the world has this romantic notion that drug discovery involves a small numbers of hero scientists toiling away in a lab until – Eureka! Read More ›
June 9, 2020 John Maraganore in "Biotechnology in the Time of COVID-19: Commentaries from the Front Lin ... In a new e-book, dozens of biopharma industry leaders, including our CEO John Maraganore, share their perspectives from the industry's unique vantage point... Read More ›
June 7, 2020 Alnylam Leaders at BIO International Convention 2020/"Digital BIO" Even though the BIO International Convention has gone virtual for 2020 as a result of COVID-19, Alnylam leaders will continue to contribute to the... Read More ›

Get In Touch

Have any questions or comments about the content you see on this page?

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site